Xcout Intel
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm works to unlock and direct the power of the human immune system to develop novel therapeutics and medicines.
Subscribe to see Repertoire Immune Medicines’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Repertoire Immune Medicines at a glance
Repertoire Immune Medicines is a biotech company headquartered in United States. Xcout tracks 18 named people at Repertoire Immune Medicines, including Torben Straight Nissen (Chief Executive Officer). Xcout recorded 1 job posting from Repertoire Immune Medicines in the last 90 days.
Repertoire Immune Medicines leadership
- Torben Straight NissenChief Executive Officer
- Anthony CoylePresident, Research and Development
- Jan KisielowChief Scientific Officer, Repertoire Immune Medicines (Switzerland) Ltd.
- John DelyaniChief Business Officer
- Robert AndtbackaChief Medical Officer
- JC Gutierrez-RamosChief Science Officer, Danaher Corporation
12 more named people on record for Repertoire Immune Medicines, with roles, board committees and tenure — see the full roster →
Hiring at Repertoire Immune Medicines
Xcout recorded 1 job posting from Repertoire Immune Medicines in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Repertoire Immune Medicines's hiring signals →
Repertoire Immune Medicines competitors
A few of Repertoire Immune Medicines's closest competitors — see the full list of competitors and alternatives →
CREATE Medicines is a clinical-stage biotechnology company located in Cambridge, Massachusetts, pioneering in vivo immune programming with RNA.
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Stipple Bio, Inc. is a private biotechnology company headquartered in Cambridge, Massachusetts, United States, focused on harnessing epitope-level precision in therapeutics.
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Get Repertoire Immune Medicines's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Repertoire Immune Medicines? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Repertoire Immune Medicines in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access